{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:03:50Z","timestamp":1794535430746,"version":"4.9.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004319","name":"Shin Kong Wu Ho-Su Memorial Hospital","doi-asserted-by":"publisher","award":["2024SKHADR001"],"award-info":[{"award-number":["2024SKHADR001"]}],"id":[{"id":"10.13039\/501100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["113-2314-B-341 -001"],"award-info":[{"award-number":["113-2314-B-341 -001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-026-03912-0","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T18:54:28Z","timestamp":1769453668000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Differential impact of advanced glycation end-products on cardiovascular risk across patient populations measured by skin autofluorescence: a meta-analysis"],"prefix":"10.1186","volume":"31","author":[{"given":"Allen Cheng-Wei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Ting","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna Shu-Han","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"3912_CR1","doi-asserted-by":"publisher","unstructured":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 395(10225):709\u201333. https:\/\/doi.org\/10.1016\/s0140-6736(20)30045-3. 2020.","DOI":"10.1016\/s0140-6736(20)30045-3"},{"issue":"11","key":"3912_CR2","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1093\/cvr\/cvad083","volume":"119","author":"C Zoccali","year":"2023","unstructured":"Zoccali C, Mallamaci F, Adamczak M, et al. Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association. Cardiovasc Res. 2023;119(11):2017\u201332. https:\/\/doi.org\/10.1093\/cvr\/cvad083.","journal-title":"Cardiovasc Res"},{"issue":"9889","key":"3912_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/s0140-6736(13)60595-4","volume":"382","author":"RT Gansevoort","year":"2013","unstructured":"Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339\u201352. https:\/\/doi.org\/10.1016\/s0140-6736(13)60595-4.","journal-title":"Lancet"},{"issue":"5","key":"3912_CR4","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00125-010-1681-4","volume":"53","author":"AP Kengne","year":"2010","unstructured":"Kengne AP, Patel A, Colagiuri S, et al. The Framingham and UK prospective diabetes study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) study. Diabetologia. 2010;53(5):821\u201331. https:\/\/doi.org\/10.1007\/s00125-010-1681-4.","journal-title":"Diabetologia"},{"issue":"13","key":"3912_CR5","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296\u2013305. https:\/\/doi.org\/10.1056\/NEJMoa041031.","journal-title":"N Engl J Med"},{"key":"3912_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11071253","author":"L Caldiroli","year":"2022","unstructured":"Caldiroli L, Molinari P, Dozio E, et al. In patients with chronic kidney disease advanced glycation end-products receptors isoforms (sRAGE and esRAGE) are associated with malnutrition. Antioxidants (Basel). 2022. https:\/\/doi.org\/10.3390\/antiox11071253.","journal-title":"Antioxidants (Basel)"},{"issue":"2","key":"3912_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s001250051591","volume":"44","author":"R Singh","year":"2001","unstructured":"Singh R, Barden A, Mori T, et al. Advanced glycation end-products: a review. Diabetologia. 2001;44(2):129\u201346. https:\/\/doi.org\/10.1007\/s001250051591.","journal-title":"Diabetologia"},{"issue":"10","key":"3912_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2023.108595","volume":"37","author":"G Borderie","year":"2023","unstructured":"Borderie G, Foussard N, Larroumet A, et al. The skin autofluorescence of advanced glycation end-products relates to the development of foot ulcers in type 2 diabetes: a longitudinal observational study. J Diabetes Complications. 2023;37(10):108595. https:\/\/doi.org\/10.1016\/j.jdiacomp.2023.108595.","journal-title":"J Diabetes Complications"},{"issue":"3","key":"3912_CR9","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/ndt\/gfx371","volume":"34","author":"H Mukai","year":"2019","unstructured":"Mukai H, Svedberg O, Lindholm B, et al. Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study. Nephrol Dial Transplant. 2019;34(3):442\u20138. https:\/\/doi.org\/10.1093\/ndt\/gfx371.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"3912_CR10","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/ckj\/sfz099","volume":"13","author":"RJH Martens","year":"2020","unstructured":"Martens RJH, Broers NJH, Canaud B, et al. Advanced glycation endproducts and dicarbonyls in end-stage renal disease: associations with uraemia and courses following renal replacement therapy. Clin Kidney J. 2020;13(5):855\u201366. https:\/\/doi.org\/10.1093\/ckj\/sfz099.","journal-title":"Clin Kidney J"},{"key":"3912_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101194","volume":"42","author":"MS Hosseini","year":"2021","unstructured":"Hosseini MS, Razavi Z, Ehsani AH, et al. Clinical significance of non-invasive skin autofluorescence measurement in patients with diabetes: a systematic review and meta-analysis. EClinicalMedicine. 2021;42:101194. https:\/\/doi.org\/10.1016\/j.eclinm.2021.101194.","journal-title":"EClinicalMedicine"},{"key":"3912_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ijcard.2016.02.095","volume":"210","author":"D Deluyker","year":"2016","unstructured":"Deluyker D, Ferferieva V, Noben JP, et al. Cross-linking versus RAGE: how do high molecular weight advanced glycation products induce cardiac dysfunction? Int J Cardiol. 2016;210:100\u20138. https:\/\/doi.org\/10.1016\/j.ijcard.2016.02.095.","journal-title":"Int J Cardiol"},{"issue":"1","key":"3912_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-024-00905-9","volume":"30","author":"Y Chen","year":"2024","unstructured":"Chen Y, Meng Z, Li Y, et al. Advanced glycation end products and reactive oxygen species: uncovering the potential role of ferroptosis in diabetic complications. Mol Med. 2024;30(1):141. https:\/\/doi.org\/10.1186\/s10020-024-00905-9.","journal-title":"Mol Med"},{"key":"3912_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-024-07639-0","author":"B Wang","year":"2024","unstructured":"Wang B, Jiang T, Qi Y, et al. AGE-RAGE axis and cardiovascular diseases: pathophysiologic mechanisms and prospects for clinical applications. Cardiovasc Drugs Ther. 2024. https:\/\/doi.org\/10.1007\/s10557-024-07639-0.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"3","key":"3912_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152376","volume":"11","author":"AI Serban","year":"2016","unstructured":"Serban AI, Stanca L, Geicu OI, et al. RAGE and TGF-\u03b21 cross-talk regulate extracellular matrix turnover and cytokine synthesis in AGEs exposed fibroblast cells. PLoS ONE. 2016;11(3):e0152376. https:\/\/doi.org\/10.1371\/journal.pone.0152376.","journal-title":"PLoS ONE"},{"issue":"4","key":"3912_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4330\/wjc.v4.i4.90","volume":"4","author":"Z Hegab","year":"2012","unstructured":"Hegab Z, Gibbons S, Neyses L, et al. Role of advanced glycation end products in cardiovascular disease. World J Cardiol. 2012;4(4):90\u2013102. https:\/\/doi.org\/10.4330\/wjc.v4.i4.90.","journal-title":"World J Cardiol"},{"issue":"18","key":"3912_CR17","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.118.009833","volume":"7","author":"I Cavero-Redondo","year":"2018","unstructured":"Cavero-Redondo I, Soriano-Cano A, \u00c1lvarez-Bueno C, et al. Skin autofluorescence-indicated advanced glycation end products as predictors of cardiovascular and all-cause mortality in high-risk subjects: a systematic review and meta-analysis. J Am Heart Assoc. 2018;7(18):e009833. https:\/\/doi.org\/10.1161\/jaha.118.009833.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"3912_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-020-00676-4","volume":"21","author":"HE Boersma","year":"2021","unstructured":"Boersma HE, van Waateringe RP, van der Klauw MM, et al. Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes. BMC Endocr Disord. 2021;21(1):14. https:\/\/doi.org\/10.1186\/s12902-020-00676-4.","journal-title":"BMC Endocr Disord"},{"issue":"9","key":"3912_CR19","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1007\/s11255-020-02543-6","volume":"52","author":"SR Varikasuvu","year":"2020","unstructured":"Varikasuvu SR, Sulekar H, Aloori S, et al. The association of non-invasive skin autofluorescence measurements with cardiovascular and all-cause mortality in hemodialysis patients: a meta-analysis. Int Urol Nephrol. 2020;52(9):1757\u201369. https:\/\/doi.org\/10.1007\/s11255-020-02543-6.","journal-title":"Int Urol Nephrol"},{"issue":"Suppl 5","key":"3912_CR20","doi-asserted-by":"publisher","first-page":"v20","DOI":"10.1093\/ndt\/gfm294","volume":"22","author":"F Galli","year":"2007","unstructured":"Galli F. Protein damage and inflammation in uraemia and dialysis patients. Nephrol Dial Transplant. 2007;22(Suppl 5):v20-36. https:\/\/doi.org\/10.1093\/ndt\/gfm294.","journal-title":"Nephrol Dial Transplant"},{"key":"3912_CR21","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1046\/j.1523-1755.2000.07615.x","volume":"76","author":"T Miyata","year":"2000","unstructured":"Miyata T, Kurokawa K, De Strihou CV. Relevance of oxidative and carbonyl stress to long-term uremic complications. Kidney Int Suppl. 2000;76:S120-5. https:\/\/doi.org\/10.1046\/j.1523-1755.2000.07615.x.","journal-title":"Kidney Int Suppl"},{"key":"3912_CR22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/978-981-13-8871-2_20","volume":"1165","author":"SF Chen","year":"2019","unstructured":"Chen SF, Chen M. Complement activation in progression of chronic kidney disease. Adv Exp Med Biol. 2019;1165:423\u201341. https:\/\/doi.org\/10.1007\/978-981-13-8871-2_20.","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"3912_CR23","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.kint.2017.11.034","volume":"93","author":"N Rabbani","year":"2018","unstructured":"Rabbani N, Thornalley PJ. Advanced glycation end products in the pathogenesis of chronic kidney disease. Kidney Int. 2018;93(4):803\u201313. https:\/\/doi.org\/10.1016\/j.kint.2017.11.034.","journal-title":"Kidney Int"},{"issue":"4","key":"3912_CR24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.exger.2010.11.007","volume":"46","author":"S Yamagishi","year":"2011","unstructured":"Yamagishi S. Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes. Exp Gerontol. 2011;46(4):217\u201324. https:\/\/doi.org\/10.1016\/j.exger.2010.11.007.","journal-title":"Exp Gerontol"},{"issue":"3","key":"3912_CR25","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1681\/asn.2011060607","volume":"23","author":"AK Jain","year":"2012","unstructured":"Jain AK, Blake P, Cordy P, et al. Global trends in rates of peritoneal dialysis. J Am Soc Nephrol. 2012;23(3):533\u201344. https:\/\/doi.org\/10.1681\/asn.2011060607.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"3912_CR26","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1053\/j.ackd.2011.09.001","volume":"18","author":"R Sinnakirouchenan","year":"2011","unstructured":"Sinnakirouchenan R, Holley JL. Peritoneal dialysis versus hemodialysis: risks, benefits, and access issues. Adv Chronic Kidney Dis. 2011;18(6):428\u201332. https:\/\/doi.org\/10.1053\/j.ackd.2011.09.001.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"1","key":"3912_CR27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/089686089701700112","volume":"17","author":"AB Dawnay","year":"1997","unstructured":"Dawnay AB, Millar DJ. Glycation and advanced glycation end-product formation with icodextrin and dextrose. Perit Dial Int. 1997;17(1):52\u20138.","journal-title":"Perit Dial Int"},{"issue":"1","key":"3912_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2215\/cjn.05350709","volume":"5","author":"NJ McIntyre","year":"2010","unstructured":"McIntyre NJ, Chesterton LJ, John SG, et al. Tissue-advanced glycation end product concentration in dialysis patients. Clin J Am Soc Nephrol. 2010;5(1):51\u20135. https:\/\/doi.org\/10.2215\/cjn.05350709.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"3912_CR29","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/ki.2010.515","volume":"79","author":"J Perl","year":"2011","unstructured":"Perl J, Nessim SJ, Bargman JM. The biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions: benefit at bench, bedside, or both? Kidney Int. 2011;79(8):814\u201324. https:\/\/doi.org\/10.1038\/ki.2010.515.","journal-title":"Kidney Int"},{"issue":"6","key":"3912_CR30","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/mnh.0000000000000062","volume":"23","author":"SK Mallipattu","year":"2014","unstructured":"Mallipattu SK, Uribarri J. Advanced glycation end product accumulation: a new enemy to target in chronic kidney disease? Curr Opin Nephrol Hypertens. 2014;23(6):547\u201354. https:\/\/doi.org\/10.1097\/mnh.0000000000000062.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"3912_CR31","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1210\/jc.2007-1817","volume":"93","author":"SY Goh","year":"2008","unstructured":"Goh SY, Cooper ME. Clinical review: the role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab. 2008;93(4):1143\u201352. https:\/\/doi.org\/10.1210\/jc.2007-1817.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"3912_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2021.101273","volume":"48","author":"A Larroumet","year":"2022","unstructured":"Larroumet A, Foussard N, Majchrzak C, et al. Skin autofluorescence predicts mortality in type 1 diabetes. Diabetes Metab. 2022;48(2):101273. https:\/\/doi.org\/10.1016\/j.diabet.2021.101273.","journal-title":"Diabetes Metab"},{"issue":"5","key":"3912_CR33","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00125-009-1308-9","volume":"52","author":"HL Lutgers","year":"2009","unstructured":"Lutgers HL, Gerrits EG, Graaff R, et al. Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus. Diabetologia. 2009;52(5):789\u201397. https:\/\/doi.org\/10.1007\/s00125-009-1308-9.","journal-title":"Diabetologia"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-026-03912-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-03912-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-03912-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T13:05:57Z","timestamp":1771419957000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-026-03912-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3912"],"URL":"https:\/\/doi.org\/10.1186\/s40001-026-03912-0","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable because the study utilized publicly available, previously published, anonymized data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"320"}}